District court ruled in favor of Watson in Mucinex patent suit


[Bloomberg]

Watson in press release announced that he United States District Court for the Southern District of Florida has ruled that Watson’s generic versions of Mucinex(R), Mucinex(R) D and Mucinex(R) DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252 (the “‘252 Patent”).

A U.S. appeals court in August overturned a ruling that generic-drug maker Perrigo Co. of Allegan, Michigan, didn’t infringe the same patent. That case was sent back to the court for further review.

[CAFC Order in perrigo case]

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s